#1
|
|||
|
|||
ÌÐÒ ãîëîâíîãî ìîçãà â ïñèõèàòðèè
Õîòåëîñü áû óçíàòü ìíåíèå ïñèõèàòðîâ îòíîñèòåëüíî íàçíà÷åíèÿ ÌÐÒ ãîëîâíîãî ìîçãà.
Âåäü íåâðîïàòîëîãè è ïñèõèàòðû èçó÷àþò îäèí è òîò æå îðãàí, íî åñëè ó ïåðâûõ ñòàëî ïîâñåäíåâíîñòüþ íàçíà÷àòü ÌÐÒ ïðè áîëüøèíñòâå öåðåáðàëüíûõ ïðîáëåì, òî, ïðàêòèêà ïîêàçûâàåò, ïñèõèàòðû íå ðàñöåíèâàþò ñâîè äèàãíîçû êàê ïîêàçàíèÿ ê ÌÐÒ ãîëîâíîãî ìîçãà. Èëè ÿ îøèáàþñü? Åñëè òàê, òî ÷òî ÿâëÿåòñÿ òîðìîçîì? |
#2
|
||||
|
||||
Ïîòîìó,÷òî ïñèõèàòðû,ïðèíèìàþòñÿ çà ñâîå ëå÷åíèå,ïîñëå èñêëþ÷åíèÿ îðãàíè÷åñêîé ïàòîëîãèè.Ïîýòîìó íàäîáíîñòè â èññëåäîâàíèè ìîçãà ñ ýòîé öåëüþ íåò.
À ìîæåò áûòü îíè ñ÷èòàþò,÷òî äóøà àïðèîðè íå íàõîäèòñÿ â ãîëîâå.
__________________
doctor Ðolonsky israel Ñíèìêè ñìîòðþ òîëüêî â ïðÿìîì ïîêàçå.,áåç íåîáõîäèìîñòè ñêà÷èâàíèÿ. Ïðîñüáà ïîêàçûâàòü ñíèìêè â ïðàâèëüíîì ïîëîæåíèè. |
#3
|
|||
|
|||
1) ïîâñåäíåâíàÿ ïðàêòèêà ïîêàçûâàåò, ÷òî ýòî íå òàê - ïðèíèìàþòñÿ, è äîñòàòî÷íî àêòèâíî, à ïîñëå âûÿâëÿåòñÿ îðãàíè÷åñêàÿ (íåâðîëîãè÷åñêàÿ, íåéðîõèðóðãè÷åñêàÿ) ïàòîëîãèÿ.
2) ìíîãèå çàáîëåâàíèÿ â ïñèõèàòðèè èìåþò îñíîâîé ãðóáûå îðãàíè÷åñêèå ïîâðåæäåíèÿ ìîçãà. |
#4
|
||||
|
||||
Öèòàòà:
2-è ÷òî,âûÿâëåíèåì ýòîé ïàòîëîãèè äîëæåí çàíèìàòüñÿ ïñèõèàòð,èëè æå,êàê ÿ è ïèñàë,ýòî âûÿâëÿåòñÿ âðà÷àìè ñîìàòè÷åñêîé ïàòîëîãèè,è ïðè íàëè÷èè ïñèõèàòðè÷åñêîé ïàòîëîãèè,êîòîðàÿ ñîïðîâîæäàåò òå èëè èíûå èçìåíåíèÿ,ïàöèåíò ïîëó÷àåè ïñèõèàòðè÷åñêóþ ïîìîùü. 3-×åã Âû,ñîáñòâåííî äîáèâàåòåñü,óçíàòü èìååò ëè ïðàâî ïñèõèàòð íàïðàâëÿòü íà MRT,èëè ïî÷åìó îíè ýòîãî íå äåëàþò,òî åñòü íå íàïðàâëÿþò.
__________________
doctor Ðolonsky israel Ñíèìêè ñìîòðþ òîëüêî â ïðÿìîì ïîêàçå.,áåç íåîáõîäèìîñòè ñêà÷èâàíèÿ. Ïðîñüáà ïîêàçûâàòü ñíèìêè â ïðàâèëüíîì ïîëîæåíèè. |
#5
|
||||
|
||||
 Ìîñêâå èç ñîìàòè÷åñêîãî îòäåëåíèÿ â äóðäîì íåâîçìîæíî ïåðåâåñòè áåç êîíñóëüòàöèè íåâðîëîãà è ñàõàðà êðîâè. Áûâàåò òàê, ÷òî ïñèõèàòðû ìîãóò íàñòîÿòü íà ÌÑÊÒ/ÌÐÒ - ÷òî åñòü. Ïîòîìó ÷òî â áîëüíèöå îáû÷íî ïàöèåíòû ñõîäÿò ñ óìà íå ïðîñòî òàê À â àìáóëàòîðíîì ïîðÿäêå, íàâåðíîå, áûâàåò âñÿêîå.
|
#6
|
|||
|
|||
 ÷àñòíîñòè, êòî-íèáóäü ðèñêí¸ò ïîñòàâèòü äèàãíîç áîëåçíè Àëüöãåéìåðà áåç ÌÐÒ ãîëîâíîãî ìîçãà?
|
#7
|
||||
|
||||
Èìåíà è ôàìèëèè ïåðå÷èñëèòü? Ìîãó íà÷àòü. Ïðèõîæó îäíàæäû â ðåàíèìàöèþ ñìîòðåòü áåññîçíàòåëüíîå òåëî. Ðåàíèìàòîëîã ãîâîðèò - âñå ôèãíÿ, òóò áîëåçíü Àëüöãåéìåðà äàâíî, îíà äàâíî òàêàÿ, çàáèðàéòå ñ ÷åì-íèáóäü, ðåàíèìèðîâàòü òóò íå îò ÷åãî. Îòïèñûâàþñü, íå çàáèðàþ, ñêàíäàëþ, ãîâîðþ, ÷òî íàäî ñíà÷àëà ñíèìîê ñäåëàòü, äèàãíîç óòî÷íèòü è âîîáùå-òî äûõàòåëüíûå ïóòè ïðîñàíèðîâàòü, ïîñêîëüêó áóëüêàåò òàê, ÷òî çà îòåê ëåãêèõ ïðèíÿòü ìîæíî.  êîðèäîðå âñòðå÷àþñü ñ ðîäñòâåííèêàìè.
- À ÷òî, ó íåå ïðàâäà áîëåçíü Àëüöãåéìåðà? - Òàê ýòî âû ó ìåíÿ ñïðàøèâàåòå? - Íó, íàì òàê â ðåàíèìàöèè ñêàçàëè.. |
|
#8
|
||||
|
||||
Äëÿ äèàãíîñòèêè áîëåçíè Àëüöãåéìåðà êàê òàêîâîé - ÌÐÒ íåîáÿçàòåëüíî.
Ó îòíîñèòåëüíî ìîëîäûõ - ïðîâîäèòñÿ íåéðîâèçóàëèçàöèÿ (ìîæíî è ÊÒ) äëÿ èñêëþ÷åíèÿ îáðàòèìûõ ïðè÷èí äåìåíöèè (îïóõîëè, ñóáäóðàëüíûå ãåìàòîìû, ÍÒÃ). À óæå ÌÐÒ ñ èçìåðåíèåì îáúåìà ãèïïîêàìïà (áåç ýòîãî - òîëêó ìàëî) è SPECT, êîòîðûå ïðîâîäÿò â íåêîòîðûõ ìåñòàõ - áîëüøå èç ëþáâè ê èñêóññòâó. |
#9
|
|||
|
|||
Íå ñîãëàñåí.
Ïðè ñóùåñòâóþùèõ ìåòîäàõ äèàãíîñòèêè ÁÀ (à òî÷íåå - èõ îòñóòñòâèè) ïîñëåäíÿÿ ïðåâðàùàåòñÿ â áîëåçíü èñêëþ÷åíèÿ - è áåç ÌÐÒ ñòàâèòü òàêîé äèàãíîç (à òàêæå èíûõ äåìåíöèé) èçëèøíå ñàìîíàäåÿííî. |
#10
|
||||
|
||||
Öèòàòà:
Ïðåäëàãàþ òåìó äèññåðòàöèè-"íåîáõîäèìîñòü ÌÐÒ,äëÿ äèàãíîñòèêè ÁÀ. Âîò è äîêàçûâàéòå, ïî âñåì ïðàâèëàì íàóêè. Âàøå- Öèòàòà:
__________________
doctor Ðolonsky israel Ñíèìêè ñìîòðþ òîëüêî â ïðÿìîì ïîêàçå.,áåç íåîáõîäèìîñòè ñêà÷èâàíèÿ. Ïðîñüáà ïîêàçûâàòü ñíèìêè â ïðàâèëüíîì ïîëîæåíèè. |
#11
|
|||
|
|||
Ìèðîâàÿ ïðàêòèêà ïî ÁÀ, â ÷àñòíîñòè, áàçèðóåòñÿ íà ñëåäóþùèõ, èçâåñòíûõ Âàì, êðèòåðèÿõ: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] - â êîòîðûå ïðÿìî è êîñâåííî (÷åðåç èñêëþ÷åíèå èíûõ çàáîëåâàíèé) íåïðåìåííî âõîäèò ÐÊÒ/ÌÐÒ.
Àíàëîãè÷íûì îáðàçîì â êðèòåðèÿõ øèçîôðåíèè (òàêîãî æå äèàãíîçà èñêëþ÷åíèÿ) ïî DSM-IV-TR ïîä áóêâîé E) ïèøóò: "Ïðè÷èíà íå â ïðè¸ìå íàðêîòèêîâ èëè ëåêàðñòâ è íå â êàêîé-òî íåïñèõè÷åñêîé áîëåçíè". Èíòåðåñíî, ãäå, íå ïðîâîäÿ ÌÐÒ, áóäåò ãàðàíòèÿ, ÷òî â ëîáíîé äîëå íå ðàñò¸ò îïóõîëü??? |
#12
|
||||
|
||||
Òå êðèòåðèè çà 17 ëåò íå ðàç ïåðåñìàòðèâàëèñü, íî íèêòî íå ñïîðèò, ÷òî íåîáõîäèìî èñêëþ÷àòü îáðàòèìûå äåìåíöèè â íà÷àëå. Óâåðåí, òå ïñèõèàòðû, êîòîðûå ðàáîòàþò ñ òàêèìè áîëüíûìè - ýòî õîðîøî çíàþò è äåëàþò.
×òî êàñàåòñÿ ðîëè ÌÐÒ â äèàãíîñòèêå ÀÄ - â îáû÷íîì âèäå, áåç âîëþìåòðèè, ìåòîä ÷óâñòâèòåëåí, íî àáñîëþòíî íåñïåöèôè÷åí.  ñâÿçè ñ ýòèì â íîâûõ êðèòåðèÿõ î íåì ñêàçàíî - ìèíèìóì. Âñå áîëüøå ðå÷ü îá îïðåäåëåíèè áåòà-àìèëîèäà â ëèêâîðå è ìîçãå ñ ïîìîùüþ PET. Ññûëàòüñÿ ëó÷øå íà ÷òî-òî ïîíîâåå: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#13
|
|||
|
|||
Ïîòîìó ìíå è õîòåëîñü óñëûøàòü îòâåò ïðîôåññèîíàëüíîãî ïñèõèàòðà - 100% ëè áîëüíûì, êîòîðûì îí âûñòàâèë äèàãíîçû ÁÀ èëè Sch, ïðîâîäèëàñü ÌÐÒ ãîëîâíîãî ìîçãà?
Íåòó ñïîðà - óòðèðóÿ, â 99% îò ýòîãî íè÷åãî íå èçìåíèòñÿ, à â 1% áóäåò êðàéíå íåïðèÿòíàÿ îøèáî÷íàÿ äèàãíîñòèêà. |
#15
|
||||
|
||||
Ê òåìå:
Clinical Diagnosis Remarkably Accurate in Early-Onset Dementias Experts in dementia predicted neuropathology using only clinical history and neuropsychological screening exams. Across dementia subtypes, definitive diagnosis has historically been reserved for cases with neuropathological confirmation or positive genetic testing. These authors examined the accuracy of prospectively obtained clinical diagnoses compared with autopsy-based diagnoses for 228 patients evaluated at an early-onset dementia clinic (mean age at onset, 57 ±8 years). Diagnoses were rendered using a standardized approach that used the following information: illness course; the relative prominence of cognitive, behavioral, and motor signs and symptoms; the specific pattern of cognitive deficits elicited by clinical history-taking and neuropsychological testing; and the degree of selectivity of the cognitive deficits. During the period of clinical examination of this cohort (1983–2008), the field of dementia study saw considerable clinical and molecular advances, and the authors adjusted the diagnostic algorithm to address these (e.g., diagnostic criteria for dementia with Lewy bodies, updated pathological criteria for frontotemporal lobar degeneration [FTLD]) to include the biomarker TDP-43). However, the authors report that no biomarkers, including neuroimaging, were used to make the clinical diagnoses. The two most common clinical diagnoses in the series — Alzheimer disease (AD; 46% of cases) and FTLD (42% of cases) — had 97% sensitivity and specificity. The few cases diagnosed erroneously included two patients with clinical diagnoses of behavioral-variant frontotemporal dementia (bvFTD) found to have AD at autopsy and four patients with diagnoses of bvFTD who had corticobasal degeneration pathology. Comment: The authors acknowledge the referral bias in this sample, reflected in the higher-than-expected percentage of FTLD cases and relative paucity of vascular pathology. This bias may in fact be a strength of the authors' diagnostic algorithm: The referral bias harnesses expert clinical evaluation in a subspecialty dementia clinic to make accurate neuropathological predictions, with the ultimate goal of using disease-specific therapeutic interventions. Even as researchers develop and investigate increasingly novel (and expensive) biomarkers for neurodegenerative disease, focused clinical history and neurobehavioral examination can be remarkably accurate. Snowden JS et al. The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships. Brain 2011 Aug 11 |